哈药股份
(600664)
| 流通市值：91.93亿 | | | 总市值：91.93亿 |
| 流通股本：25.19亿 | | | 总股本：25.19亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 12,021,256,198.55 | 8,124,702,491.09 | 4,174,424,028.39 | 16,175,856,239.24 |
| 营业收入 | 12,021,256,198.55 | 8,124,702,491.09 | 4,174,424,028.39 | 16,175,856,239.24 |
| 二、营业总成本 | 11,509,872,116.8 | 7,724,597,864 | 3,907,797,043.17 | 15,304,315,131.09 |
| 营业成本 | 8,892,808,851.49 | 5,927,433,454.75 | 3,061,636,859.52 | 11,607,227,744.2 |
| 税金及附加 | 90,722,520.92 | 62,808,028.55 | 32,425,072.35 | 125,561,578.44 |
| 销售费用 | 1,797,826,889.62 | 1,257,536,286.52 | 582,635,212.56 | 2,561,922,958.87 |
| 管理费用 | 606,439,310.7 | 396,417,371.94 | 192,564,664.79 | 836,122,858.85 |
| 研发费用 | 93,697,452.17 | 60,070,516.54 | 31,122,681.26 | 136,434,672.73 |
| 财务费用 | 28,377,091.9 | 20,332,205.7 | 7,412,552.69 | 37,045,318 |
| 其中:利息费用 | 31,791,591.33 | 20,741,080.24 | 10,533,258.03 | 60,067,602.8 |
| 其中:利息收入 | 20,915,983.91 | 17,160,464.37 | 6,629,528.8 | 37,028,958.35 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 293,032.8 | - | - | 12,437,230.26 |
| 资产处置收益 | 4,270,973.73 | 3,985,875.71 | 1,563,746.69 | 1,032,392.61 |
| 资产减值损失(新) | -16,518,830.11 | -16,519,763.68 | 0 | -100,066,623.53 |
| 信用减值损失(新) | -63,749,889.34 | -41,831,461.24 | -8,776,021.8 | 39,372,000.69 |
| 其他收益 | 50,027,178.21 | 20,516,338.38 | 12,640,227.49 | 65,888,807.23 |
| 四、营业利润 | 485,706,547.04 | 366,255,616.26 | 272,054,937.6 | 890,204,915.41 |
| 加:营业外收入 | 2,304,802.6 | 1,429,728.41 | 217,180.13 | 5,098,942.71 |
| 减:营业外支出 | 6,972,263.77 | 5,761,313.09 | 595,007.19 | 20,297,752.32 |
| 五、利润总额 | 481,039,085.87 | 361,924,031.58 | 271,677,110.54 | 875,006,105.8 |
| 减:所得税费用 | 139,344,422.73 | 98,044,757.83 | 52,951,619.53 | 184,398,274.21 |
| 六、净利润 | 341,694,663.14 | 263,879,273.75 | 218,725,491.01 | 690,607,831.59 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 341,694,663.14 | 263,879,273.75 | 218,725,491.01 | 690,607,831.59 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 328,594,490.47 | 259,705,144.23 | 212,929,359.73 | 628,846,598.33 |
| 少数股东损益 | 13,100,172.67 | 4,174,129.52 | 5,796,131.28 | 61,761,233.26 |
| 扣除非经常损益后的净利润 | 288,864,230.08 | 244,155,901.1 | 203,986,037.99 | 585,820,306.77 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.13 | 0.1 | 0.08 | 0.25 |
| (二)稀释每股收益 | 0.13 | 0.1 | 0.08 | 0.25 |
| 八、其他综合收益 | 297,097.02 | 476,694.89 | 14,226.63 | -3,156,731.76 |
| 归属于母公司股东的其他综合收益 | 297,097.02 | 476,694.89 | 14,226.63 | -3,156,731.76 |
| 九、综合收益总额 | 341,991,760.16 | 264,355,968.64 | 218,739,717.64 | 687,451,099.83 |
| 归属于母公司股东的综合收益总额 | 328,891,587.49 | 260,181,839.12 | 212,943,586.36 | 625,689,866.57 |
| 归属于少数股东的综合收益总额 | 13,100,172.67 | 4,174,129.52 | 5,796,131.28 | 61,761,233.26 |
| 公告日期 | 2025-10-25 | 2025-08-23 | 2025-04-26 | 2025-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |